Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Roxro Pharma Inc.

Latest From Roxro Pharma Inc.

Takeda Gets GI Candidate – And Possibly Company – In Altos Deal

In the latest in a string of deals, Takeda's agreement to acquire global rights to Altos's gastroparesis candidate - and possibly the company itself - gives the Japanese giant another asset in its core gastrointestinal area.

BioPharmaceutical Asia Pacific

2011 Scrip Asia 100 - M&A Watch Asia

M&A Watch: Selected Asian M&A deals, March 2010 to March 2011


Intranasal ketorolac for pain launched in the US, by Daiichi Sankyo's Luitpold Pharma

Daiichi Sankyo's US subsidiary Luitpold Pharmaceuticals, through its newly established division known as Regency Therapeutics, has launched the non-steroidal anti-inflammatory drug (NSAID) ketorolac, Sprix (ketorolac tromethamine) nasal spray, for the short term (up to five days) management of moderate to moderately severe pain that requires opioid analgesia.


New appointments at Symphogen

Symphogen, a private Danish biopharmaceutical company developing antibody therapeutics to treat cancer, and infectious and autoimmune diseases, has appointed Dr Ivan Horak chief scientific officer and medical officer and Gayle Mills chief business officer. Dr Horak joins from Enzon, where he was most recently president of R&D, having been chief scientific officer since 2005. Ms Mills had served as executive vice-president of business operations and chief business officer at Roxro Pharma for the past five years until the company's acquisition by Luitpold Pharmaceuticals, a subsidiary of Daiichi Sankyo.

Cancer Companies
See All

Company Information

  • Industry
  • Pharmaceuticals